Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial (Q39150558)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 November 2016

Language	Label	Description	Also known as
English	Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial	scientific article published on 24 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

phase I clinical trial

0 references

pulmonary fibrosis

1 reference

based on heuristic

inferred from title

idiopathic pulmonary fibrosis

1 reference

based on heuristic

inferred from title

author name string

Marilyn K Glassberg

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Julia Minkiewicz

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Rebecca L Toonkel

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Emmanuelle S Simonet

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gustavo A Rubio

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Darcy DiFede

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Shirin Shafazand

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Aisha Khan

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Marietsy V Pujol

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Vincent F LaRussa

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Lisa H Lancaster

11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Glenn D Rosen

12

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Joel Fishman

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yolanda N Mageto

14

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Adam Mendizabal

15

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Joshua M Hare

16

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

24 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

151

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

971-981

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential ef

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Bone marrow-derived progenitor cells in pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Usual interstitial pneumonia: histologic correlation with high-resolution CT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6026255

30 August 2018

Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CHEST.2016.10.061

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39150558&oldid=2194724143"